Screening Strategy Reduces Incidence of Immigration-Related Tuberculosis
By LabMedica International staff writers Posted on 29 Mar 2015 |

Image: Mycobacterium tuberculosis culture revealing this organism’s typical morphologic characteristics of colorless rough surface, which are seen in M. tuberculosis colonial growth (Photo courtesy of Dr. George Kubica).
Implementation of the culture-based algorithm may have substantially reduced the incidence of tuberculosis (TB) among newly arrived, foreign-born persons in the United States of America.
Immigration has a substantial effect on the incidence of TB, so immigrants and refugees bound for the USA are required to have overseas TB screening. Before 2007, a smear-based algorithm that could not diagnose smear-negative/culture-positive TB was used to screen this population.
Scientists at the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) revised the screening strategy to use a more inclusive culture-based algorithm. They reviewed health records to determine the increase of smear-negative/culture-positive Mycobacterium tuberculosis or TB cases diagnosed overseas between 2007 and 2012 and compared that figure with the decline of reported TB cases among foreign-born persons within one year after arrival in the USA.
Of the 3,212,421 arrivals of immigrants and refugees from 2007 to 2012, a total of 1,650,961 (51.4%) were screened by the smear-based algorithm and 1,561,460 (48.6%) were screened by the culture-based algorithm. Among the 4,032 TB cases diagnosed by the culture-based algorithm, 2,195 (54.4%) were smear-negative/culture-positive. Before implementation (2002 to 2006), the annual number of reported cases among foreign-born persons within one year after arrival was relatively constant (range, 1,424 to 1,626 cases; mean, 1,504 cases), but decreased from 1,511 to 940 cases during implementation (2007 to 2012). During the same period, the annual number of smear-negative/culture-positive TB cases diagnosed overseas among immigrants and refugees bound for the USA by the culture-based algorithm increased from 4 to 629.
The authors concluded that the increased annual number of TB cases detected in immigrants and refugees closely matched in magnitude a decrease in the number reported TB cases, suggesting that the culture-based algorithm effectively reduced TB incidence. To further reduce the TB incidence in foreign-born populations, consideration should be given to expanding TB screening to students, exchange visitors, and temporary workers from countries with a high incidence of TB, as well as finding novel strategies to address the large numbers of foreign-born persons with latent TB infection The study was published on March 17, 2015, in the journal Annals of Internal Medicine.
Related Links:
[US] Centers for Disease Control and Prevention
Immigration has a substantial effect on the incidence of TB, so immigrants and refugees bound for the USA are required to have overseas TB screening. Before 2007, a smear-based algorithm that could not diagnose smear-negative/culture-positive TB was used to screen this population.
Scientists at the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) revised the screening strategy to use a more inclusive culture-based algorithm. They reviewed health records to determine the increase of smear-negative/culture-positive Mycobacterium tuberculosis or TB cases diagnosed overseas between 2007 and 2012 and compared that figure with the decline of reported TB cases among foreign-born persons within one year after arrival in the USA.
Of the 3,212,421 arrivals of immigrants and refugees from 2007 to 2012, a total of 1,650,961 (51.4%) were screened by the smear-based algorithm and 1,561,460 (48.6%) were screened by the culture-based algorithm. Among the 4,032 TB cases diagnosed by the culture-based algorithm, 2,195 (54.4%) were smear-negative/culture-positive. Before implementation (2002 to 2006), the annual number of reported cases among foreign-born persons within one year after arrival was relatively constant (range, 1,424 to 1,626 cases; mean, 1,504 cases), but decreased from 1,511 to 940 cases during implementation (2007 to 2012). During the same period, the annual number of smear-negative/culture-positive TB cases diagnosed overseas among immigrants and refugees bound for the USA by the culture-based algorithm increased from 4 to 629.
The authors concluded that the increased annual number of TB cases detected in immigrants and refugees closely matched in magnitude a decrease in the number reported TB cases, suggesting that the culture-based algorithm effectively reduced TB incidence. To further reduce the TB incidence in foreign-born populations, consideration should be given to expanding TB screening to students, exchange visitors, and temporary workers from countries with a high incidence of TB, as well as finding novel strategies to address the large numbers of foreign-born persons with latent TB infection The study was published on March 17, 2015, in the journal Annals of Internal Medicine.
Related Links:
[US] Centers for Disease Control and Prevention
Latest Microbiology News
- Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more